A multi-centre, two-stage, open label phase II study to assess the efficacy and safety of APO866 in the treatment of patients with advanced melanoma

Update Il y a 4 ans
Reference: EUCTR2006-000910-19

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this clinical trial is to determine the anti-tumor activity of APO866 in patients with advanced cutaneous melanoma.


Inclusion criteria

  • The medical condition is advanced cutaneous melanoma stage IV or unresectable stage III